AFM
CYTXW

Anson Funds Management’s Cytori Therapeutics Inc Warrant CYTXW Stock Holding History

Anson Funds Management’s Portfolio CYTXW Stock Details CYTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-450,000
Closed -$914K – 106
2016
Q3 		$914K Hold
450,000
– – 0.2% 43
2016
Q2 		$941K Buy
+450,000
New +$302K 0.18% 45

Other funds holding CYTXW

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Anson Funds Management's CYTXW Position: Q4 2016 in Review

Anson Funds Management sold out of Cytori Therapeutics Inc Warrant (CYTXW) in Q4 2016, closing a stake of 450,000 shares — an estimated $914K sold.

Anson Funds Management first reported a position in CYTXW in Q2 2016 and held it in 2 quarters. The position peaked at $941K in Q2 2016. 3 funds tracked by Wall St. Rank hold CYTXW as of Q4 2016.

  • Anson Funds Management reported no remaining Cytori Therapeutics Inc Warrant position as of Q4 2016 after selling out during the quarter.
  • Anson Funds Management sold 450,000 Cytori Therapeutics Inc Warrant shares in Q4 2016, an estimated $914K.
  • Anson Funds Management first reported a position in Cytori Therapeutics Inc Warrant in Q2 2016 and held it in 2 quarters.
  • Anson Funds Management's Cytori Therapeutics Inc Warrant position peaked at $941K in Q2 2016.
  • 3 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Warrant as of Q4 2016.

Based on Anson Funds Management's 13F filing for Q4 2016, filed 14 Feb 2017.